rs374587860

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS1

The NM_003923.3(FOXH1):​c.15C>T​(p.Ser5Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00101 in 1,414,240 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00087 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0010 ( 0 hom. )

Consequence

FOXH1
NM_003923.3 synonymous

Scores

3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: -0.860

Publications

1 publications found
Variant links:
Genes affected
FOXH1 (HGNC:3814): (forkhead box H1) FOXH1 encodes a human homolog of Xenopus forkhead activin signal transducer-1. FOXH1 protein binds SMAD2 and activates an activin response element via binding the DNA motif TGT(G/T)(T/G)ATT. [provided by RefSeq, Jul 2008]
PPP1R16A (HGNC:14941): (protein phosphatase 1 regulatory subunit 16A) Myosin light chain kinase and phosphatase (MLCP) complexes control the phosphorylation states of regulatory myosin light chains, which is crucial for muscle and intracellular movement. MLCPs typically contain a catalytic protein phosphatase 1 (PP1c) subunit, a myosin phosphatase targeting (MYPT) subunit, and another smaller subunit. The protein encoded by this gene represents an MYPT subunit, which is responsible for directing PP1c to its intended targets. However, while the phosphorylation of other MYPT members results in PP1c inactivation, phosphorylation of the encoded protein by protein kinase A results in PP1c activation. [provided by RefSeq, Jan 2020]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_003923.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 8-144475742-G-A is Benign according to our data. Variant chr8-144475742-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 215825.
BP7
Synonymous conserved (PhyloP=-0.86 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000873 (133/152274) while in subpopulation AMR AF = 0.00216 (33/15306). AF 95% confidence interval is 0.00158. There are 0 homozygotes in GnomAd4. There are 57 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003923.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FOXH1
NM_003923.3
MANE Select
c.15C>Tp.Ser5Ser
synonymous
Exon 1 of 3NP_003914.1O75593

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FOXH1
ENST00000377317.5
TSL:1 MANE Select
c.15C>Tp.Ser5Ser
synonymous
Exon 1 of 3ENSP00000366534.4O75593
FOXH1
ENST00000935088.1
c.15C>Tp.Ser5Ser
synonymous
Exon 1 of 3ENSP00000605147.1
FOXH1
ENST00000935090.1
c.15C>Tp.Ser5Ser
synonymous
Exon 1 of 3ENSP00000605149.1

Frequencies

GnomAD3 genomes
AF:
0.000874
AC:
133
AN:
152156
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00216
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000828
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00101
Gnomad OTH
AF:
0.00288
GnomAD2 exomes
AF:
0.000814
AC:
51
AN:
62666
AF XY:
0.000702
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00160
Gnomad ASJ exome
AF:
0.000809
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000945
Gnomad NFE exome
AF:
0.00126
Gnomad OTH exome
AF:
0.00254
GnomAD4 exome
AF:
0.00102
AC:
1293
AN:
1261966
Hom.:
0
Cov.:
32
AF XY:
0.00100
AC XY:
612
AN XY:
609244
show subpopulations
African (AFR)
AF:
0.000183
AC:
5
AN:
27378
American (AMR)
AF:
0.00176
AC:
24
AN:
13620
Ashkenazi Jewish (ASJ)
AF:
0.000781
AC:
14
AN:
17922
East Asian (EAS)
AF:
0.00
AC:
0
AN:
32634
South Asian (SAS)
AF:
0.000462
AC:
25
AN:
54100
European-Finnish (FIN)
AF:
0.000228
AC:
10
AN:
43800
Middle Eastern (MID)
AF:
0.00141
AC:
7
AN:
4958
European-Non Finnish (NFE)
AF:
0.00115
AC:
1168
AN:
1015968
Other (OTH)
AF:
0.000775
AC:
40
AN:
51586
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
58
117
175
234
292
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000873
AC:
133
AN:
152274
Hom.:
0
Cov.:
33
AF XY:
0.000765
AC XY:
57
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.000385
AC:
16
AN:
41556
American (AMR)
AF:
0.00216
AC:
33
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000829
AC:
4
AN:
4826
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10628
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00101
AC:
69
AN:
67996
Other (OTH)
AF:
0.00285
AC:
6
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000831
Hom.:
0
Bravo
AF:
0.00103

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Holoprosencephaly sequence (2)
-
1
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
8.3
DANN
Benign
0.85
PhyloP100
-0.86
PromoterAI
-0.0022
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs374587860;
hg19: chr8-145701125;
COSMIC: COSV56760377;
COSMIC: COSV56760377;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.